With obesity enveloping over 40% of U.S. adults and consequently escalating the prevalence of severe obesity to an unsettling 9% in 2020, its ramifications in prompting public health issues are palpable.
The crux of the concern emerges not merely from the statistics but from the ensuing health complications such as cardiovascular diseases (CVD), diabetes, and certain cancers, all of which are propelled by factors like hyperlipidemia, hypertension, chronic inflammation, and oxidative stress.
Spotlight on LDL and Its Compromised Functionality in Obesity
One of the pivotal players in cardiovascular health is Low-Density Lipoprotein (LDL), often tagged as “bad cholesterol” due to its role in depositing cholesterol in arteries, thereby fostering CVD.
A study emanating from Boston University Chobanian & Avedisian School of Medicine casts a spotlight on the exacerbated detrimental role of LDL amidst obesity.
Unveiling the “Worsened” LDL in Obesity
Dr. Shobini Jayaraman and her team have elucidated that the adversity embedded in LDL becomes amplified in the context of obesity due to inflammation.
Here, LDL’s cholesterol delivery mechanism pivots from a normal to a jeopardizing mode, fostering cholesterol retention in arterial walls and culminating in plaque formation.
In scrutinizing LDL particles from severely obese individuals, pre and post (6 and 12 months) bariatric surgery, and contrasting them with lean controls, the research underscored an aberration in LDL functionality in the obese demographic.
The altered LDL demonstrated a diminished efficiency in cholesterol delivery to LDL receptors and an inclination to either favor cholesterol delivery to scavenger receptors or adhere to arterial walls, both underscoring an enhanced risk of atherosclerosis and hence, CVD.
Weight Loss: A Pathway Towards Mitigating LDL Dysregulation?
Promisingly, the investigation also spotlighted a progressive improvement in LDL quality post-bariatric surgery as the obesity-induced inflammation receded with weight loss.
Although the LDL quality did not parallel that of lean individuals, a clear correlation was noted between LDL quality and weight loss, indicating a diminishing risk of CVD as weight normalized.
Bridging Scientific Understanding and Public Health
The study underscores a pivotal insight: the degradation in LDL quality, propelled by obesity-induced inflammation, heightens CVD risk, while the amelioration of LDL quality via weight loss mitigates this risk.
This finding not only holds promise for bariatric surgery patients but potentially for a broader demographic struggling with overweight and obesity issues.
Thus, the lens through which LDL is viewed in obesity contexts needs to be nuanced, acknowledging that it’s not merely about reducing LDL quantities but addressing the altered quality of LDL engendered by obesity.
Dr. Olga Gursky signifies that as LDL quality continues to enhance with weight normalization, the decline in CVD risk persists, opening avenues for exploring varied weight loss approaches and their impact on LDL quality and CVD risk mitigation.
These findings, appearing in the Journal of Lipid Research, propel a profound understanding of the intertwined dynamics of obesity, LDL functionality, and cardiovascular health, paving the path for further research and potential therapeutic strategies.
If you care about nutrition, please read studies about berry that can prevent cancer, diabetes, and obesity, and 12 foods that lower blood pressure.
For more information about heart health, please see recent studies about Aspirin linked to higher risk of heart failure, and results showing this drug could reduce heart disease, fatty liver, obesity.
The research findings can be found in the Journal of Lipid Research.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
